Quest Diagnostics, Inc. (NYSE:DGX) on 05/18/2020 declared a dividend of $ 0.5600 per share payable on July 22, 2020 to shareholders of record as of July 08, 2020.
Quest Diagnostics, Inc. (NYSE:DGX) has paid dividends since 2004, has a current dividend yield of 2.0165646076% and has increased its dividends for 8 successive years.
Quest Diagnostics, Inc.'s market cap is $ 14,854,950,560 and has a PE ratio of 19.12. The stock price closed yesterday at $ 111.08 and has a 52 week low/high of $ 73.02 and $ 125.00.
Quest Diagnostics provides diagnostic information services. Co.'s diagnostic information segment provides information based on the menu of routine, non-routine and clinical testing and anatomic pathology testing, and other diagnostic information services. Co.'s testing capabilities, includes services for the predisposition, diagnosis, treatment and monitoring of cancers and other diseases, and provides tests in several fields, including endocrinology, immunology, neurology and oncology. Co.'s diagnostic solutions provides risk assessment services for the life insurance industry, as well as provides healthcare organizations and clinicians health information technology solutions.
For more information on Quest Diagnostics, Inc. click here.
Quest Diagnostics, Inc. current dividend information as per the date of this press release is: